Clinicopathological data of all cases
| Group | No of cases | Mean (range) age (years) | Sex (M/F) | Mean (range) tumour size (mm) | TNM stage | Grade | Progression |
|---|---|---|---|---|---|---|---|
| Group 1, >95% tumour necrosis; group 2, 50–94% tumour necrosis; group 3, <50% tumour necrosis. | |||||||
| NS, not staged; LTFU, lost to follow up. | |||||||
| Group 1 | 4 | 58 (27–82) | 3/1 | 80.2 (40–180) | I: 3 | 1: 2 | 0/4 |
| II: 1 | 2: 2 | 0/4 | |||||
| III: 0 | 3: 0 | ||||||
| IV: 0 | 4: 0 | ||||||
| Group 2 | 10 | 63 (32–79) | 7/3 | 103.5 (28–270) | I: 2 | 1: 1 | 3/9 (0, 22, 50) and 1 LTFU |
| II: 3 | 2: 5 | ||||||
| III: 4 | 3: 5 | ||||||
| IV: 0 | 4: 0 | ||||||
| NS: 1 | |||||||
| Group 3 | 20 | 62 (44–80) | 13/7 | 106.1 (25–350) | I: 6 | 1: 2 | 6/18 (1, 5, 15, 16, 31, 33) and 2 LTFU |
| 2: 15 | |||||||
| II: 4 | 3: 3 | ||||||
| III: 10 | 4: 0 | ||||||
| IV: 0 | |||||||